Molecular Characterization of Proteus spp. from Patients Admitted to Hospitals in Erbil City

Authors

DOI:

https://doi.org/10.25156/ptj.v11n2y2021.pp95-99

Keywords:

Proteus mirabilis, Proteus vulgaris, Polymerase chain reaction, ureR, Urease C

Abstract

The study was carried out to detect the identity of Proteus spp. isolated from various clinical specimens in Erbil City by polymerase chain reaction (PCR) technique. Specimens were of urine, wounds swabs, burn swabs, vaginal swabs, ear swabs, eye swabs, and sputum. Fifty-one Proteus isolates, (47) Proteus mirabilis, and (4) Proteus vulgaris, were undergone PCR assay using specific primers, targeting the genes ureR and Urease C (ureC), that encode for urease enzyme as a virulence factor of Proteus species. It was found that all isolates of Proteus mirabilis yielded positive result for ureR gene with an amplicon length of 225 bp, as well as, all isolates of Proteus vulgaris exhibited positive PCR products on gel for ureC gene with an amplicon length of 263 bp. Our results indicate that ureR and ureC based PCR method seems to be an appropriate method for characterization of Proteus mirabilis and Proteus vulgaris respectively.

Downloads

Download data is not yet available.

References

Adnan, M., I. H. Aziz and M. S. Al-Deresawi. 2014. Molecular detection of Proteus mirabilis using PCR technique among urinary tract infection patients. Iraqi J. Biotecnol. 13(2): 35-47.

Alatrash, A. M. and A. Al-Yaseen. 2017. Detection of ureR AND ureC among Proteus mirabilis. Asian J. Pharm. Clin. Res. 10(8): 386.

AL-Imam, M. and B. Al-Rubaii. 2016. The influence of some amino acids, vitamins and anti-inflammatory drugs on activity of chondroitinase produced by Proteus vulgaris caused urinary tract infection. Iraqi J. Sci. 57(4A): 2412-2421.

AL-Saadi, B. Q., S. J. Kadhum and S. H. Muhaiesen. 2015. Isolation of uropathogens from pediatric associated UTI, with special focus on the detection of Proteus vulgaris. Iraqi J. Biotechnol. 14(1): 77-84.

Armbruster, C. E. and H. L. Mobley. 2012. Merging mythology and morphology: The multifaceted lifestyle of Proteus mirabilis. Nat. Rev. Microbiol. 10: 743.

Desjardins, P. and D. Conklin. 2010. NanoDrop microvolume quantitation of nucleic acids. J. Vis. Exp. 45: 2565.

Feglo, P. K. S., Y. Gbedema, S. N. A. Quay, Y. Adu-Sarkodie and C. O. Okrah. 2010. Occurrence, species distribution an antibitics resistance of Proteus isolates: A case study at the Komfo Anokye teaching hospital in Ghana. Int. J. Pharma Sci. Res. 1(9): 347-352.

Jacobsen, S.M., D. J. Stickler, H. L. T. Mobley and M. E. Shirtliff. 2008. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin. Microbiol. Rev. 21(1): 26-59.

Jones, B. D. and H. L. Mobley. 1988. Proteus mirabilis urease: Genetic organization, regulation, and expression of structural genes. J. Bacteriol. 170(8): 3342-3349.

Jones, S. M., J., Yerly, Y. Hu, H. Ceri and R. Martinuzzi. 2007. Structure of Proteus mirabilis biofilms grown in artificial urine and standard laboratory media. J. Microbiol. Lett. 268(1): 16-21.

Kamel, F. H. and S. F. Jarjes. 2015. Essentials of Bacteriology and Immunology. Erbil Polytechnic University, Iraq.

Kamil, T. D. and S. F. Jarjes. 2019. Isolation, identification and antibiotics susceptibility determination of Proteus species obtained from various clinical specimens in Erbil city. Polytech. J. 9(2): 86-92.

Latif, B., S. Z. Aleabdyn and I. Ahmed. 2017. A Comparative bacteriological and molecular study on some virulence factor of Proteus spp isolated from clinical and environment specimens. Int. J. Curr. Res. Aca. Rev. 5(5): 26-33.

Lee, J. and R. A. Deininger. 2000. Survival of bacteria after ozonation. J. Int. Ozone Assoc. 22(1): 65-75.

Li, X. and H. L. Mobley. 2002. Vaccines for Proteus mirabilis in urinary tract infection. Int. J. Antimicrob. Agents. 19: 461-465.

Limanskiĭ, A., V. Minukhin, O. Limanskaia, N. Pavlenko, M. Mishina and A. Tsygenenko. 2005. Species-specific detection of Proteus vulgaris and Proteus mirabilis by the polymerase chain reaction. Zh. Mikrobiol. Epidemiol. Immunobiol. 3: 33-39.

Lu, J., C. Perng, S. Lee. and C. Wan. 2000. Use of PCR with universal primers and restriction endonuclease digestions for detection and identification of common bacterial pathogens in cerebrospinal fluid. J. Clin. Microbiol. 38(6): 2076-2080.

Mobley, H. and G. R. Chippendale. 1990. Hemagglutinin, urease and hemolysin production by Proteus mirabilis in clinical sources. J. Infect. Dis. 161: 525-530.

Mobley, H. and R. Belas. 1995. Swarming and pathogenicity of Proteus mirabilis in the urinary tract. Trends Microbial. 3: 280-284.

Mobley, H., M. Island and P. R. Hausinger. 1995. Molecular biology of microbial ureases. Microbiol. Rev. 59: 451-480.

Mohammed, S. O., O. A. Elshahaby, E. E. Hafez, A. K. Mohammed and E. Ahmed. 2014. Characterization and purification of urease enzyme from new Proteus mirabilis strain. J. Adv. Sci. Res. 5: 8-11.

Nielubowicz, G. and H. Mobley. 2010. Hostpathogen interactions in urinary tract infections. Nat. Rev. Urol. 7: 430-441.

O’Hara, C. F. W. Brenner, A. G. Steigerwalt, B. C. Hill, B. P. Holmes, A. D. Grimont, P. M. Hawkey, J. L. Penner, J. M. Miller and D. J. Brenner. 2000. Classification of Proteus vulgaris biogroup 3 with recognition of Proteus hauseri sp. nov., nom. rev. and unnamed Proteus genomospecies 4, 5 and 6. Int. J. Syst. Evol. Microbiol. 50: 1869-1875.

Pal, N., N. Sharma, R. Sharma, S. Hooja and R. Maheshwari. 2014. Prevalence of multidrug (MDR) and extensively drug resistant (XDR) Proteus species in a tertiary care hospital, India. Int. J. Curr. Microbiol. Appl. Sci. 3: 243-252.

Poore, C. and H. Mobley. 2003. Differential regulation of the Proteu mirabilis urease gene cluster by UreR and H-NS. Microbiology. 149(12): 3383-3394.

Sambrook, J. and D. W. Rusell. 2001. Molecular Cloning: A Laboratory Manual. 3rd ed. Cold Spring Harbor, Laboratory Press, New York.

Schabereiter-Gurtner, C., S. Maca, S. Rölleke, K. Nigl, J. Lukas, A. Hirschl, W. Lubitz and T. Barisani-Asenbauer. 2001. 16S rDNAbased identification of bacteria from conjunctival swabs by PCR and DGGE fingerprinting. Invest. Ophthalmol. Vis. Sci. 42: 1164- 1171.

Shoket, H., S. Ali, R. K. Gupta and V. K. Mishra. 2014. Occurrence of Proteus mirabilis associated with vegetable samples in Dehradun, Uttarakhand, India. Int. J. Curr. Microbiol. Appl. Sci. 3(7): 958-961.

Zhang, W., Z. Niu, K. Yin, P. Liu and L. Chen. 2013. Quick identification and quantification of Proteus mirabilis by polymerase chain reaction (PCR) assays. Ann. Microbiol. 63: 683-689.

Downloads

Published

2021-12-30

How to Cite

Kamil, T. D., & Jarjes, S. F. (2021). Molecular Characterization of Proteus spp. from Patients Admitted to Hospitals in Erbil City. Polytechnic Journal, 11(2), 95-99. https://doi.org/10.25156/ptj.v11n2y2021.pp95-99

Issue

Vol. 11 No. 2 (2021):

Section

Research Articles

License

Copyright (c) 2021 Treska Dh. Kamil, Sanaria F. Jarjes

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Authors who publish with this journal agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License [CC BY-NC-ND 4.0] that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).